Mikhail Blagosklonny is a renowned professor, researcher, and philanthropist. Aside from that, he is highly motivated by the need to ensure that all individuals around the globe receive quality treatment irrespective of their economic background. As a medical researcher, Mikhail Blagosklonny devotes a considerable portion of his time studying aging and cancer. In this case, he focuses on the link between the two and more precisely the reason that older persons above a given age are common victims of cancer.Mikhail has played an instrumental role in the advancement of the oncology field through his valuable research. Away from that, he has outdone himself not only as an expert in his line of work but also as an oncology professor at New York-based Roswell Park Cancer Institute. Through his work, Mikhail Blagosklonny has become an inspirational figure to his students and peers as well.In his research, Mikhail largely focuses on finding an effective treatment for cancer that will not be as expensive and excruciating as current treatments today. He strives to come up with a way that can get rid of cancerous cells in the body without harming the normal cells, which are responsible for healing both the body and mind after receiving cancer treatment for many months or years. Furthermore, Mikhail hopes that his findings will inspire many other researchers around the globe to expand on his work.
Benefits of Rapamycin
Rapamycin or otherwise known as Sirolimus is a drug that is used in preventing organ transplant rejection. It is also normally used in treating a rare lung disease and coating coronary stents. Additionally, Rapamycin is also known as Rapamune in the pharmacy market, which is a popular cancer drug. Mikhail Blagosklonny is well-known for championing the use of the drug with the sole purpose of boosting human being’s lifespan. As far as Rapamycin is concerned, it boasts certain distinctive qualities. In fact, it has immunosuppressant properties that make it an effective anti-rejection drug for organ transplants. It has also proven to be an ideal drug for treating victims of hemolytic-uremic syndrome, a rare condition that occurs due to the combination of low platelet count, kidney failure, and anemia.
Furthermore, Rapamycin can be used to treat lymphangioleiomyomatosis(LAM), a rare lung condition that usually affects women in the childbearing age bracket.Rapamycin is significantly used as a coating for the coronary stents. This application of the drug helps to avoid the occurrence of re-stenosis, which can occur after a balloon angioplasty procedure. Rapamycin‘s antiproliferative qualities also come in handy for the treatment of cancer. In this case, the drug has to be taken in the appropriate dosage in a bid to boost the body’s immune response towards tumors. According to Mikhail Blagosklonny, Rapamycin increases the longevity of humans. The research is yet to be put to the test in a bid to validate his work. Additionally, research has shown that the drug can prevent cognitive defects and brain lesions in mice, which is good news for the research on Alzheimer’s disease.